Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Health Care Angel Investors in Israel in October 2024

Last updated: Oct 2024 A list of 50 angel investors that invest in Health care startups based in Israel. We rank investors based on the number of investments they made in Health care companies from Israel. We update this investor list every month.

Top 50 Health Care Angel Investors in Israel in October 2024

Investor	Health Care Israel investments
Marius Nacht	5
Howard Morgan	3
Zohar Gilon	3
Ran Tuttnauer	3
Yehuda Zisapel	2
Assaf Wand	2
Oren Dobronsky	2
Mazal CB	2
Shmuel Cabilly	2
Moshe Gaon	2
Yaron Samid	2
Prof. Rafael Beyar	2
Ron C	2
Dov Moran	2
Shimon Eckhouse	2
Shimon Eckhouse	2
Yasmin Lukatz	1
Sake Bosch	1
David Golan	1
Nancy Spielberg	1
Nir Greenberg	1
Raoul Stein	1
Chris Mansi	1
Shahar Tzafrir	1
Ronald Cohen	1
Beni Nofech	1
Menachem Winfield	1
Leonard Speiser	1
Tamara Minick-Scokalo	1
Ole T. Jensen	1
Rick Klausner	1
Ron Sabar	1
Jacques R. Seguin	1
Rafi Benary	1
Haim Chizic	1
Shai Rephaeli	1
Amir Gross	1
Daniel Koss	1
David Agus	1
Steve Barsh	1
Bradley M. Bloom	1
Tzachi Arabov	1
Joshua Riff	1
Itsik Danziger	1
Danny Hadar	1
David E. Weekly	1
Moshe Shoham	1
Rafi Gidron	1
Nir Kalkstein	1
Alan Patricof	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point. Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987.

Investment focus

Artificial Intelligence, Machine Learning, Health Care
Series A, Funding Round, Seed
Israel, United States, Germany

Portfolio highlights

CPTx — At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug development, which is crucial for addressing complex disease states involving multiple binding sites, such as viruses, cancer, and autoimmune diseases.
Wisdo Health — Our award-winning social health platform utilizes SDOH assessments and pro-social measures to increase quality of life and decrease medical spending.
WaveBL — WAVE BL lets you digitally issue, transfer, sign, endorse and surrender trade documents while cutting costs and eliminating fraud.

Howard Morgan is currently the Chairman of B Capital. He co-founded First Round Capital with Josh Kopelman as the first professional Seed Stage Fund, where he remains Senior Advisor. Prior to First Round, Howard helped found Idealab with Bill Gross, and served as President of Renaissance Technologies, which he co-founded with Jim Simons. Prior tohis move into the business of technology, Howard served as a professor at the Wharton School and the Moore School, both at the University of Pennsylvania, as well as at Cornell University. He is also an Executive Fellow at UC Berkeley. Howard’s research on user interface technology and the optimization of computer networks was critical to bringing the ARPAnet to Philadelphia in the 1970s. Through this early internet participation, he helped corporate and government agencies use technology to improve the efficiency of both large and small organizations. He also has deep experience with very large databases, and served as the first Editor of the ACM Transactions on Database Systems Journal. Throughout his career, Howard has sought out great people and nurtured them so that they could realize their dreams. His mentees have included both PhD students researching a key topic, and early stage entrepreneurs building companies and taking them from seed stage through initial public offerings. He currently serves as a Director of Idealab, and he is on the board of several non-profits including Cold Spring Harbor Laboratories and Math For America. He has also served on a number of public company Boards, including Franklin Electronic Publishers and Internet Brands, Inc. He was CEO of Kentek and Franklin during various turnover or transitional periods and in 1997 he was named Delaware Valley Entrepreneur of the Year. Howard is a respected author and a frequent speaker at major industry conferences. Howard received a PhD in Operations Research from Cornell University in 1968, and a BS in Physics from City College of the City University of New York in 1965.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Series A, Series B
United States, Israel, India

Portfolio highlights

HATCH — HATCH is the first of its kind Giving Intelligence Platform. An AI-powered portal for Fundraisers, Marketers and Volunteers to streamline and Maximize their impact. A new home for a new world of giving!
Garden — Garden helps lawyers and companies automate invention harvesting, generate novel patents, and analyze infringements in a couple clicks.
OrdinalsBot — We make it easy to inscribe ordinals. Like, really easy.

Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994.

Investment focus

Software, Internet, Health Care
Seed, Series A, Series B
Israel, United States

Portfolio highlights

CADY — CADY utilizes AI technology to automate the analysis of electrical schematics
Loora — Unlock your full potential with Loora, your very own AI English tutor. Engage in real conversations with Loora anytime, anywhere, and on any topic!
Annabella — The only Breast Pump that simulates your baby's tongue to optimize milk output naturally and efficiently. Our Tongue Technology is known to stimulate milk-producing hormones.

Ran Tuttnauer

Investment focus

Health Care, Big Data, Medical Device
Seed, Series A
Israel, Canada, United States

Portfolio highlights

Innovopro — Bringing a unique chickpea protein platform to the global food & beverage market, for creating nutritious, tasty, and sustainable food products.
Solidify — The Marketplayz platform helps you find the perfect creators to promote your products. It utilizes AI-powered technology to enable advertisers and creators to connect through a one-stop, self-service marketplace.
Geneyx — Geneyx offers a superior NGS data analysis and interpretation platform, Harnessing genetic data to guide digital insights for rare and germline disorders.

Mr. Yehuda Zisapel (EE,MSc, MBA, DHC) is the founder and president of the RAD-Bynet Group, a leading pioneering association of Israeli companies active in the development, production and marketing of innovative solutions for the data communications industry, and Chairman of RAD. The RAD-Bynet Group grew out of Bynet Data Communications, whichMr. Zisapel founded in 1975 as a small private company that marketed data communications products. Bynet represented major international vendors and was the first to introduce cutting-edge technologies into the Israeli market. Today, the Bynet Group is comprised of eight companies active in both the Israeli and Eastern European markets in such fields as systems integration, cabling, testing, outsourcing, and software development. Following the arrival of Mr. Zisapel’s brother, Zohar, who joined him in 1981, a wide range of industrial activity was spawned from within the newly established RAD, the first of the RAD Group companies. In the years following its successful launch, twenty-four additional independent hi-tech companies were opened to develop, produce and market a wide variety of advanced data communications products.

Investment focus

Medical Device, Medical, Health Care
Funding Round, Series A, Seed
Israel

Portfolio highlights

Carteav — Our mission is to create and distribute autonomous low-speed vehicles (LSVs) that inspire mass-market adoption on a global scale.
Rewire — Secure financial services designed to help migrants make cross-border money transfers. Rewire offers great rates, fast delivery, multilingual customer support
Laminate Medical — Laminate Medical Technologies is developing a new, external support device for AV fistulas, to be implanted during the fistula creation surgical procedure. The VasQ Device alleviates wall tension and regulates fistula geometry where an undesired narrowing of the vein and/or frequent blockages of the blood vessels may occur during the firstyear. Use of Laminate Medical Technology’s novel device aims to drive a change in the hemodialysis vascular access treatment paradigm and bring about a significant reduction in the annual fistula failure rate, thereby reducing kidney-failure related complications, re-interventions, and the cost burden of vascular access complications.

Assaf Wand is the Founder and Executive Chairman of Hippo Insurance. He previously worked at Sabi (Sold to Urbio) as a Founder and CEO. Assaf Wand attended Reichman University (IDC Herzliya).

Investment focus

Insurance, Health Care, Information Technology
Seed, Series A, Series B
United States, Brazil, France

Portfolio highlights

RoadFlex — Start saving more on fuel. Competitive discounts. No PG needed to apply. Apply now and get your new fuel card approved in 1 day.
Fairmatic — Powered by data and AI, focused on rewarding fleet safety with savings. Finally, a smarter insurance option designed to put fleets in control.
Modern Life — Modern Life is a tech-enabled life insurance brokerage. With a focus on empowering advisors, Modern Life offers advanced technology solutions to digitally streamline advisors’ practices and expert brokerage support. With Modern Life, advisors nationwide can compare quotes from top carriers in minutes, perform data-driven underwriting assessments,manage clients from an integrated dashboard, and receive comprehensive deal support.

Entrepreneur at heart. Angel investor in past two decades. I had the privilege to invest in the following startups, mostly at seed level: Houzz(Unicorn), TripActions(Unicorn), Hippo(Unicorn), HomeLight, Domestika, Loop Commerce, RedKix, Duda, YouNow, OwnerListens... But mostly, I am known as Oren from Oren's Hummus :)

Investment focus

FinTech, Software, Customer Service
Seed, Series A, Angel
United States, Israel

Portfolio highlights

Openbase — Find and compare the best open-source packages in hundreds of categories - withpowerful metrics and user reviews
Annabella — The only Breast Pump that simulates your baby's tongue to optimize milk output naturally and efficiently. Our Tongue Technology is known to stimulate milk-producing hormones.
Annabella Tech — Annabella is the only breast pump in the world with a patented mechanism that replicates the tongue and other inner parts of the baby's mouth. By simulating baby's suckling motion, the pump triggers mothers' natural reflex, allowing more milk to be extracted in less time. Annabella is small, quiet, portable and rechargeable - it canbe used in any place at any time and fit to a small hand bag. It has only two parts that needs to be washed and assembled. It is controlled by an app that records the pumping session and adjusts the pumping plan to fit to the mothers' personal need or suggests a better suited one.

Mazal CB

Investment focus

Health Care, Therapeutics, Medical Device
Seed, Pre-Seed
Israel

Portfolio highlights

DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.

Dr. Cabilly is a highly regarded scientist, an investor and an experienced Board Member of several companies. He is currently a Board Member of Medasense Biometrics Ltd. He previously worked for several companies including as the Co-Founder and a Chief Scientist of Ethrog Biotechnology which was sold to Invitrogen. Dr. Cabilly graduated fromthe Hebrew University (Ph.D., Immunology), and was a Post-Doctoral fellow at the City of Hope Research Institute heading a joint City of Hope/Genentech project where he developed a new technology for recombinant antibody production. This invention was patented in world patents “The old Cabilly” and “The New Cabilly patent”. Today there are already 20 drugs in the market based on this technology among which are Herceptin, Rituxan, Traceba, Raptiva, Xolair and more.

Investment focus

Health Care, Medical, Artificial Intelligence
Funding Round, Series B, Series C
Israel, United States

Portfolio highlights

Treato — Treato automatically collects the massive amount of patient-written health experiences from blogs and forums and, with advanced Natural Language Processing (NLP), extracts relevant information, connects the dots and creates the big picture of what people say about their medications and conditions.Treato's big data analytics are availablein a consumer site and as an in-depth service for pharmaceutical marketers.Treato's Consumer site (
DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.

Business entrepreneur and investor in startups. For the past 20 years developer of new initiatives and ideas. CEO, Chairman of companies, political strategist and advertising expert. Lead public opinion campaigns for people and issues from breast cancer, to national elections to the Israeli-Palestinian peace negotiations. Founding Partner atmybulb.vcOwner of the Gaon Holding Group; Executive Director in the group's companies, focusing on development and marketing products and services for the global Water Smart Grid. Member of the AquaAgro Fund Investment committee, a 50 Million dollar Israeli Venture Capital Fund, focused only on developing innovative water and agriculture technologies, as well as other innovative clean technologies.

Investment focus

Advertising, Association, Social Media Marketing
Seed, Series A, Convertible Note
Israel, United States

Portfolio highlights

Apester — Supercharge your marketing and funnel with interactive content experiences that generate more leads, engage and convert users, and boost retention
Yoocan — Yoocan is a global community for people with disabilities and their families, discover empowering stories, find support, and connect with a world that understands you.
IndieFlow — IndieFlow developed a workflow management platform for the music industry. The platform provides a centralized platform to manage music industry workflows and streamline the major building blocks of an artist’s career. It enables users to manage creative projects, distribute to streaming platforms, collect roylaties, register music with royaltycollection societies, promote music, book gigs, receive payments and more.

Yaron Samid is an Israeli-American technology entrepreneur, investor, and startup community builder. Yaron is the founder of TechAviv, the 3K-member global Israeli startup founders club, and is the managing partner of TechAviv Founder Partners, a pre-seed venture fund, backed and powered by over 100 of the world’s most successful company builders.Previously, Yaron was the founder and CEO at BillGuard (Acq. by Prosper), founder & CPO at Pando (Acq. by Microsoft), and a founding board director at CloudLock (Acq. by Cisco) and Pond5.Yaron lives in Tel Aviv with his family and is a regular guest lecturer at Stanford and Columbia Business School. He attended Technion - Israel Institute of Technology and the University of Maryland.

Investment focus

Software, Apps, Machine Learning
Seed, Pre-Seed, Series A
United States, Israel, Brazil

Portfolio highlights

bxblue — bxblue is a marketplace for personal loans in Brazil explicitly targeting pensioners and Government workers because they can they take loans secured by their guaranteed income. Because of that banks can deduct the payment directly from the paycheck, leading to an apr 10x lower than credit cards. Payroll secured loans are the most affordablepersonal loan in Brazil, and they represent 60% of the personal loans in the country. It is a 40bn dollar/year marke, completely offline. We are taking this entire market online.
Emedgene — Applying machine learning to genomics. Accelerate NGS data analysis and automate variant classification with evidence curated from the literature. From sample to report.
Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.

Prof. Rafael Beyar

Investment focus

Medical, Medical Device, Machine Learning
Seed, Series A
Israel

Portfolio highlights

MedHub-AI — MedHub-AI develops deep-learning video analysis algorithms that provide accurate diagnostic insights and practical guidance for physicians. Users can incorporate its algorithm into medical video systems to improve the decision-making process for cardiologists and other physicians. Its technology uses multiple technological and big-data processingmethods designed to handle a massive amount of clinical data, both visual and textual. It designs its algorithms to improve physicians' performance and shorten procedure times by providing a multilayered automated system that is implemented from diagnosis to practical procedural guidance and documentation. It currently offers solutions for the cardiology and gastroenterology markets.

Ron C

Investment focus

Health Care, Therapeutics, Medical Device
Seed, Pre-Seed
Israel

Portfolio highlights

DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.

Dov Moran is the Managing Partner of Grove Ventures. He previously worked at modu as the Founder, Chairman, and CEO. Dov Moran attended Technion.

Investment focus

Semiconductor, Hardware, Health Care
Series A, Seed, Series B
Israel, United States

Portfolio highlights

Rapid — RapidAPI is an API Hub that enables over 3 million developers to find, manage, and connect to APIs. RapidAPI lets developers manage all API integrations from one place and gives real-time performance metrics. RapidAPI was founded in 2014 and is headquartered in San Francisco, California.
Triple Jump Medical — Triple Jump Medical is a developer of an insulin pump intended to treat diabetic patients.
Sensible Medical Innovations — Sensible Medical Innovation Ltd. is introducing a breakthrough sensing and monitoring technology providing actionable and accurate data for guiding the management and treatment of several chronic medical conditions representing today’s biggest burden on US and worldwide healthcare budgets.

Shimon Eckhouse

Investment focus

Medical, Biotechnology, Fitness
Seed, Funding Round
Israel

Portfolio highlights

Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
Epitomee Medical — Epitomee develops paradigm-shifting ingestibledevices that deploy targeted therapies along the GI tract

Shimon Eckhouse, Ph.D., is a leading Israeli medical entrepreneur who has founded more than 20 startups including Syneron Medical Ltd., Lumenis Ltd., Ventor and Real-View Imaging. He is the current Chairman of Butterfly Medical Ltd, Active Chairman of Synerion Medical and serves as Executive of Matteris Ltd. Shimon Eckhouse served as the ChiefExecutive Officer of Syneron Medical Ltd. from April 17, 2013 to February 18, 2014. Shimon Eckhouse Co-Founded Colorchip Inc. in 2000 and served as its Chairman from 2003 to January 2004 and as Chief Executive Officer from 2001 to 2003. He served as the Chairman and Chief Executive Officer of ESC Medical Systems since its inception in 1992. He was also a co-founder and Chairman of Ventor Medical Technologies Ltd. He Co-Founded at Navotek Medical Ltd. Mr. Eckhouse took ESC public in 1996 and raised more than $250M in public offerings. He served as Chairman of Syneron Medical Ltd. from May 2004 to May 2013. He worked at Lumenis Ltd. Prior to that, Shimon Eckhouse served as Head of Product Development and Technical Director at Maxwell Technologies in San Diego, California. From 1969 to 1986, he worked at Rafael, Armament Development Authority of Israel as a Scientist, Team Leader and Head of Department and was active in various areas of research and development including lasers and electro-optics. Shimon Eckhouse has been the Founder of Orsense, Ventor, Tulip, Cardiodex, Opticul Diagnostic, C3D and NanoCyte, Inc. Shimon Eckhouse serves as the Chairman of Fluorinex Active Ltd. Shimon Eckhouse serves as the Chairman at Starling Advanced Communications Ltd. since July 2010. He serves as Chairman at OrSense Ltd. He also serves as the Chairman of the Board of Ossense Ltd., Navotek Medical Ltd., and Replicom Ltd. and Edge Medical Devices Ltd. He has been a Director at Syneron Medical Ltd. since May 2004. He serves as a Director of Cardiodex and NanoCyte, Inc. Shimon Eckhouse serves as a Member of Advisory Board of Agate Medical Investments LP and JGV Growth Equity Fund, L.P. Shimon Eckhouse serves as a Director of the Technion Israeli Institute of Technology. He served as a Director of Zend Technologies Ltd. He served as a Director of WideMed Ltd. Shimon Eckhouse has more than 25 registered patents and published more than 50 papers in leading reference journals and conferences. He holds a Ph.D. in Physics from the University of California at Irvine and a B.Sc. in Physics from the Technion Israeli Institute of Technology.

Investment focus

Health Care, Medical Device, Medical
Series B, Series C, Funding Round
Israel

Portfolio highlights

Anchora Medical — Anchora Medical focuses in simplifying of suturing in endoscopic and open surgery applications. The company develops a unique, single-use automatic suturing device for minimal invasive surgery.
Serenno Medical — Serenno Medical is a medical device company creating a urine-output measuring device for the ICU. The company is the developer of a bedside urine output measuring device for hospitalized patients, offering accurate and automatic measurements with low costs, less workload, and improved patient safety.Serenno Medical was founded in 2017 and isheadquartered in Yokne'am Illit, Israel.
RealView Imaging — RealView Imaging is pioneering the field of interactive live holography, creating a new dimension for Augmented Reality applications.

Yasmin Lukatz is the Founder and Executive Director of ICON. She attended Stanford Graduate School of Business.

Investment focus

Medical, Consumer, Wellness
Seed, Pre-Seed
Israel

Portfolio highlights

Annabella — The only Breast Pump that simulates your baby's tongue to optimize milk output naturally and efficiently. Our Tongue Technology is known to stimulate milk-producing hormones.
Arya — Arya is building the Couples Wellness category, poised to become the next billion-dollar cornerstone in the global wellness market.Couples are falling into routine and many are experiencing increased loneliness. While billions are spent on fitness, mindfulness, and sleep, emotional and physical intimacy is often neglected. We invest in swipingfor the right partner and then trying to fix it (or spend a fortune divorcing them)... but not much in between.Arya's AI concierge makes it radically easy for couples to invest in their relationship and love life, both inside and outside the bedroom - a crucial ingredient to a successful relationship.

Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.

Investment focus

Software, E-Commerce, Biotechnology
Seed, Series A, Series B
The Netherlands, France, Israel

Portfolio highlights

Fairbrics — Fairbrics is developing the first synthetic fiber with a net positive impact on climate change and capable of meeting the demand of the market.
FononTech — FononTech specializes in impulse printing.It is used to print small electronic circuits for electronic devices.
Mermade Seafoods — Mermade is a pioneering cellular aquaculture company, bringing a novel approach and mindset for the production of cell based seafood.

David Golan is the CTO at Viz.David is a Stanford statistician, and deep learning engineer.

Investment focus

Software, Wellness, Health Care
Series A
Israel

Portfolio highlights

NeuraLight — NeuraLight is a VC-backed venture on a mission to transform the lives of the billions of people impacted by neurological disorders by digitizing evaluation and care.

Nancy Spielberg - Advisory Board Member @ The Elegant Monkeys

Investment focus

Wearables, Health Care, Machine Learning
Seed
Israel

Portfolio highlights

The Elegant Monkeys — We have gathered top data science talents and world-class researchers to make emotions measurable.Digitizing human emotions opens endless applications in health, performance and lifestyle. It is a subscription-based API/SDK that utilizes AI algorithms to extract emotional state from physiological sensors data. Using physiological dataenables our customers to get emotions data without compromising usability and privacy.

Founder and CEO at Natural Intelligence.

Investment focus

Advice, Medical, Software
Angel, Pre-Seed
Israel

Portfolio highlights

Pery — Pery empowers primary care providers to deliver better mental health care, boost revenue, and reduce administrative burden. Learn more.
Superfy — Superfy gets you an answer to any question from a relevant person, using superior AI for matching people.With Superfy getting answers is simple. You ask a question, and Superfy connects you in chat with another user who already knows the answer. If you want to know the weather or exchange rates - go to Google; if you want to know what’s it liketo work at Google - ask Superfy!Superfy’s Machine Learning algorithms (US utility patent-pending) replace traditional NLP methods to crack the challenge of analyzing unstructured User Generated Content across all verticals.We launched our public iOS beta last December, and the stats are promising: 87% of our users are asking questions, 46% of our users are answering questions - over 10x the industry standard! Our users love Superfy, spending 9 minutes a day on the app, and calling it “cool”, “addictive”, “super-friendly” and “helpful” (rated 4.4 on the US Appstore).Download (iOS): https://apple.co/2CZ3HjI Or search Superfy on the App Store.Superfy was founded by Gil Schoenberg and Michal Tamir, a married couple with years of startup experience in Business, Marketing and mostly Product, both for B2C and B2B. Among our advisors is Avishai Abrahami, Wix Founder & CEO, who paved the way for Israeli B2C startups.

Raoul joined Kreos in 1999 and over the last 12 years has built a highly active presence as the leading senior credit provider to high-growth companies in Israel, as well as supporting a wide range of transactions across Europe. Mr. Stein also plays a key role in the management and execution of Kreos's overall strategy.Before joining Kreos,Raoul was an associate with Apax Partners in Israel where he invested in services and high-growth technology businesses and corporate spin-offs. He also assisted the general partners in fund-related activities such as divestment of their funds' successes traded on NASDAQ, and in general fund-raising activities such as portfolio analysis, reporting and due diligence for the purpose of raising new funds.Prior to joining Apax Partners, Raoul was an associate with Friedman , Turbidy & Co, a New York-based financial advisory firm. Raoul assisted the managing partner in several refinancing and acquisition transactions. He was involved in a refinancing of asset-backed loans with a large glass maker in the US, representing the company in its efforts to refinance its debt with banking institutions. In addition he was involved in fund-raising for a US based cosmetics company in its expansion.Raoul studied law at Bar-Ilan University. He clerked at the firm of M. Porath & Co in Tel-Aviv and passed the Bar exams in Israel in 1993. After that he graduated in 1995 from Columbia Business School with an MBA.

Investment focus

Medical, Health Care, Therapeutics
Pre-Seed
Israel

Portfolio highlights

Pery — Pery empowers primary care providers to deliver better mental health care, boost revenue, and reduce administrative burden. Learn more.

Dr Mansi is a former Neurosurgeon and the CEO of Viz.ai an Applied AI Healthcare company.They recently received FDA clearance for the first ever AI aided triage and notification platform, opening the door to AI in acute emergency healthcare. Chris is a clinician innovator, entrepreneur and optimist focused on increasing healthcare access, buildingand supporting great teams and improving provider experience. Viz.ai builds clinician facing products that enable and empower doctors, allowing them to provide the best care to patients, everytime, everywhere.

Investment focus

Health Care, Medical, Software
Series A
United States, Israel

Portfolio highlights

Canopy — Canopy's intelligent care platform enables practices to improve cancer patients' experience and outcomes in an ever changing oncology environment.
HumanFirst — HumanFirst enables better integration and analysis of digital health technologies in clinical trials.
NeuraLight — NeuraLight is a VC-backed venture on a mission to transform the lives of the billions of people impacted by neurological disorders by digitizing evaluation and care.

Shahar is a Managing Partner at TLV Partners I, II, III. Shahar is a board member in Aidoc, Buildots, Canopy Immuno-Therapeutics, Deepcure, EverAfterAI, Granulate, Guesty, Hunterz, Immunai, Odo, ScyllaDB, Shookit, Silverfort.Before joining TLV Partners Shahar was a General Partner at Magma Venture Partners III and IV and was a board member inAidoc, Applitools, CloudEndure (acquired by Amazon), Coretigo, Guesty, Indegy (acquired by Tenable), ScyllaDB, Syte, Teridion, Tonkean

Investment focus

Software, Artificial Intelligence, Information Technology
Series A, Seed, Series B
Israel, United States

Portfolio highlights

Aidoc — Powered by an exclusive aiOS, Aidoc is trusted by 1,000+ hospitals to support physician decision-making at all points of care. See how our connected system of intelligence works.
Buildots — Buildots specializes in transforming construction sites into a data-driven digital environment. Its platform enables maximum control of construction processes at minimal effort. The solution turns every site walk into valuable process data that can immediately be used for gaining full control of a certain project.
DeepCure — Pioneering a new frontier in drug development. DeepCure is building an AI engine for small-molecule drug discovery.

Ronald Cohen is Chairman of the Global Social Impact Investment Steering Group and The Portland Trust. He is a co-founder director of Social Finance UK (2007-11), Social Finance USA, and Social Finance Israel, and of Big Society Capital. He was co-founder Chair of Bridges Ventures (2002-2012).He chaired the Social Impact Investment Taskforceestablished under the UK’s presidency of the G8 (2013-2015), the Social Investment Task Force (2000-2010) and the Commission on Unclaimed Assets (2005-2007). In 2012 he received the Rockefeller Innovation Award for innovation in social finance.He co-founded and was Executive Chairman of Apax Partners Worldwide LLP (1972-2005). He was a founder director and Chairman of the British Venture Capital Association and a founder director of the European Venture Capital Association.He is a graduate of Oxford University, where he was President of the Oxford Union. He is an Honorary Fellow of Exeter College, Oxford. He has an MBA from Harvard Business School to which he was awarded a Henry Fellowship.He is a member of the Board of Dean’s Advisors at Harvard Business School and Vice-Chairman of Ben Gurion University. He is a former director of the Harvard Management Company and the University of Oxford Investment Committee. He is a former member of the Harvard University Board of Overseers (2007-2013), former Trustee of the British Museum (2005-2012) and a former trustee of the International Institute for Strategic Studies (2005-2011).In 2007, Sir Ronald published: “The Second Bounce of the Ball – Turning Risk into Opportunity”.

Investment focus

Health Care, Software, Artificial Intelligence
Series A, Funding Round, Seed
Israel, United States, Poland

Portfolio highlights

Selina — Selina is one of the world’s fastest growing hospitality brands, combining beautifully-designed accommodation with coworking spaces, wellness, recreational offerings and local experiences for today’s nomadic traveler to live, work and explore anywhere in the world.With a design-centric, technology-first and socially-minded approach to travel,Selina currently operates 24 urban, beach, jungle and mountain-side locations across eight countries and is developing a global infrastructure for nomads who want to make the world their classroom, office, and playground.
Circles - Online Group Support — Participate in online video meetings guided by an expert facilitator and gain tools for reflection that will help you feel less alone.
Masterschool — Masterschool partners with tech industry leaders to help you build your dream career. Learn online, get unlimited career support, and pay no tuition until you find a job.

Beni Nofech is a food-tech investor.

Investment focus

Food and Beverage, Food Processing, Nutrition
Pre-Seed, Series A
Israel

Portfolio highlights

Remilk — Remilk is a food-tech company that uses microbes to produce the key ingredients in milk. The company is developing technology for creating a milk substitute that is similar to cow milk in flavor, nutritional composition, composition, and functionality. It was founded in 2019 and is based in Tel Aviv, Israel.
Oshi — Alternative Protein - Stealth Mode
Mush Foods — Mush Foods is an Israeli-based food tech company, growing edible mushroom mycelium to create innovative and sustainable animal-free protein as an ingredient for the food and beverage industry. We harness the fantastic power and innate intelligence of mushrooms to face future global challenges and provide sustainable groundbreaking food solutions tothe food of the future.

Menachem Winfield is the founder and Managing Director of Starry Group. He previously worked at Seebo as an Advisor.

Investment focus

Medical, Consumer Goods, Personal Health
Seed
Israel

Portfolio highlights

Annabella — The only Breast Pump that simulates your baby's tongue to optimize milk output naturally and efficiently. Our Tongue Technology is known to stimulate milk-producing hormones.

Leonard Speiser is the Founder of Horizon 3.

Investment focus

Information Technology, Video, Big Data
Seed, Pre-Seed, Series A
Israel, United States

Portfolio highlights

Aside — Aside is the company that builds cloud-based platforms. Daffy Charitable is its first not-for-profit community platform.
MoBagel — MoBagel’s vision is to bring AI-driven decision making to enterprises through software and services. MoBagel has empowered global enterprises to extract business insights and create value from their data across industries including retail, telecom, manufacturing, banking, and more.
Magentiq Eye Ltd — Magentiq Eye Ltd. was established in 2014 with the aim to harness the most cutting edge computer vision and deep learning techniques to aid doctors in endoscopic procedures. Doctors today spend hours during Endoscopic Procedures looking at the LCD screens in order to explore, examine and treat various conditions. At Magentiq Eye we put the growingpower of Deep Learning, Image and Video Processing to the help of doctors, so they can be more accurate and effective- ultimately saving millions of lives and billions of dollars. Our first product is APDS: Automatic Polyp Detection System, developed to be used in online and offline colonoscopies. Our APDS (Automatic Polyp Detection System) can point out the suspicious locations of polyps in the videos, increasing the attentiveness of doctors during procedures, thus helping them to reduce their polyp miss-rates. Given the large population that annually undergoes colonoscopy, even a modest decrease in polyp miss-rate can save a lot of lives! The APDS- RT runs on the video feed from the endoscopic camera used by the physician in real time during the endoscopic procedure (currently only on Colonoscopy Procedure). The APDS-OFL is a software that runs in off-line mode on pre-Recorded Colonoscopy Videos. It is estimated that 40 million colonoscopy procedures are performed every year (almost 40% in the US alone). The ability of colonoscopy procedures to decrease the number of colon cancer cases has been proven without a doubt and their number expected to grow. However, researches have shown that there is about 25% of misses (undetected polyps) in those procedures, misses which can, unfortunately, cause interval cancer. Within this context The APDS can be sold as an add-on to the colonoscopy system or as a service (license per exam), paid by the clinic or hospital. Once the APDS system would be formally proven, during the next year, to improve polyp detection rate, it could be sold either jointly with the endoscopic equipment providers or it can be integrated in the colonoscopy devices.

Tamara Minick-Scokalo, Non-Executive Director at Avast.

Investment focus

Farming, Software, Wellness
Seed
Israel, United States

Portfolio highlights

Alora — Agrisea is an ocean agriculture company building the technology of today to bring peace tomorrow. The company solution genetically fortifies their crops so that they may grow in the oceans, similar to hydroponics. They create a cellular cycle of original and independent genes to promote a system that works together, rather than alone, distributingthe pressure of saltwater over a more capable group of genes.Agri design mimics nature and recreates these natural effects using the genetic material already found in their land crops. Their farms are designed with spatial optimization and a hydroponic basis in mind, wave motion is mitigated and the plant roots are positioned to absorb the necessary nutrients directly from the surrounding saltwater.
NeuraLight — NeuraLight is a VC-backed venture on a mission to transform the lives of the billions of people impacted by neurological disorders by digitizing evaluation and care.

Ole T. Jensen

Investment focus

Biotechnology, Medical Device
Funding Round
Israel

Portfolio highlights

Nobio — NobioTM developed game-changing technology with the goal to prevent medical device contamination indefinitely, as the first and only fully-integrated anti-biofilm solution. The technology core consists of extremely potent particles which are covered with a high concentration of highly-active anti-microbial structures that kill bacteria uponcontact. The NobioTM particles can be permanently embedded in many products and materials to inhibit formation of biofilm, indefinitely.

Rick Klausner is a Chief Executive Officer at Lyell Immunopharma.

Investment focus

Biotechnology, Therapeutics, Life Science
Series A, Series B, Series E
United States, Israel, United Kingdom

Portfolio highlights

bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
LifeMine Therapeutics — What if the solutions to the greatest unsolved medical problems of our time had already been evolved in nature, hiding in plain sight as molecules waiting to be mined? What if revolutionary discoveries in emerging scientific fields from gigascale DNA sequencing to artificial intelligence and synthetic biology had advanced, such that we finally had a way to mine the biosphere and bring transformative new medicines to patients in need? Our answers to these questions drive the passion and mission at LifeMine Therapeutics.

Dr. Ron Sabar, founder and CMO of Sabar Health.

Investment focus

Health Care, Bioinformatics, Personal Health
Seed
Israel

Portfolio highlights

Identifai-genetics — Revolutionizing prenatal diagnosis

Jacques Seguin is the Chairman Of The Board at Emanate Biomedical. He Attended Paris-Sud University (Paris XI) during 1975-1985.

Investment focus

Medical, Medical Device, Health Care
Seed, Pre-Seed, Funding Round
Israel, Switzerland

Portfolio highlights

Pi-Cardia — Pi-Cardia. Next Generation Valve Repair. The next frontier of treatment options for structural heart disease that provides a safe, effective, and affordable non-implant-based catheter solutions.
Althea Medical — Althea Medical is a creator of catheter devices for the treatment of patients with sub- or major pulmonary emboli. The company is developing a catheter-based solution for treating patients suffering from massive and sub-massive Pulmonary Embolism (PE). Althea Medical was established in 2020 in Tel Aviv, Israel.
CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.

Rafi Benary is the Co-founder at Innoventric and he holds a Masters’ degree from the New York University in Material Science and a Mechanical Engineering. He is an entrepreneur of 4 start-up companies, bringing them from inception to clinical stage through effective planning and execution.

Investment focus

Medical, Medical Device, Health Diagnostics
Pre-Seed
Israel

Portfolio highlights

Althea Medical — Althea Medical is a creator of catheter devices for the treatment of patients with sub- or major pulmonary emboli. The company is developing a catheter-based solution for treating patients suffering from massive and sub-massive Pulmonary Embolism (PE). Althea Medical was established in 2020 in Tel Aviv, Israel.

Haim Chizic is an individual investor.

Investment focus

Medical Device, Clinical Trials, Health Diagnostics
Seed
Israel

Portfolio highlights

MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable

Shai Rephaeli - Co-Founder and CEO @ Tutoria Digital

Investment focus

Software, EdTech, Medical
Seed
Israel

Portfolio highlights

Myndlift — Myndlift offers a therapist-guided home neurofeedback solution for mental health, using mobile and wearable technology. Home users enjoy accessible and affordable training while neuro-therapists can grow their practices with remote supervision.
Lingua.ly — Founded by Cambridge and Stanford graduates Dr. Jan Ihmels and Dr. Orly Fuhrman, Lingua.ly is a brand new way to learn a language. Collect new words from across the web with Lingua.ly's smart dictionary. Use your new vocab as you read real articles you choose. Immersion is the ultimate way to learn a language, and Lingua.ly’s free, onlinelearning platform uses “digital immersion” to give you all the same benefits no matter where you learn. Do you like to read about science and technology in your spare time? Prefer French recipes or travel magazines? Perhaps following business updates from the Middle East is key to your company’s success? Our patent pending algorithm understands your vocabulary to fill your feed with real articles from the web to suit both your level and interests. Better still, we let you practice your new words through fun games and quizzes. So, give your vocabulary a boost, create some colorful flashcards, keep your mind engaged and explore the web in a new language with Lingua.ly! Learn English, French, Spanish, Arabic, Hebrew, Dutch, Italian, Portuguese, German and Russian. Lingua.ly’s blended learning solution can be used as a stand-alone product or to complement language classes and self-study course-ware. It is cloud synced and operable via desktop or mobile and supports 18+ dictionary languages. Website: http://lingua.ly App Store: http://bit.ly/1pyL1bb Google Play: http://bit.ly/1s04YuK

Amir Gross is the CEO of Cardiovalve.

Investment focus

Medical, Health Care, Medical Device
Funding Round
Israel

Portfolio highlights

BrainQ — BrainQ is developing breakthrough precision neurology therapies using Brain Computer Interface technology....

Daniel Koss is an individual investor.

Investment focus

Medical Device, Clinical Trials, Health Diagnostics
Seed
Israel

Portfolio highlights

MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable

David Agus is an American physician and a New York Times bestselling author. He is a Professor of Medicine and Engineering at the University of Southern California. He is co-founder of Navigenics, a personalized medicine company and Applied Proteomics, as well as a CBS News contributor.

Investment focus

Health Care, Health Diagnostics, Artificial Intelligence
Series A
Israel

Portfolio highlights

Imagene AI — Imagene AI provides AI-based molecular testing for cancer, leveraging the patient's histological data for personalized therapy.Our mission at Imagene is to assist cancer patients in receiving the optimal treatment medicine can offer by leveraging AI to detect, in real-time, a broad range of cancerous biomarkers and genomic insights from thebiopsy image alone. By doing so, Imagene overcomes economical, logistical, and technological barriers to reach the full potential of precision medicine for cancer patients.Through collaborations with top-tier medical centers and pharmaceutical companies, Imagene is revolutionizing molecular screening for both clinical practice and research.Our success derives from our cutting-edge technology and talented multidisciplinary team of data scientists, biologists, software engineers, and medical experts.

Steve Barsh is a managing partner at Dreamit Ventures. He attended the University of Michigan from 1983 to 1987.

Investment focus

Health Care, Information Technology, Machine Learning
Funding Round, Seed, Series A
United States, Israel

Portfolio highlights

Keriton — Every year around 500,000 infants are admitted to one of the 1,100+ Neonatal ICUs (NICUs) across US. While mother's breast milk is important for all newborns, it is vital for the survival of these fragile patients. However, despite its critical role, the current state of breast milk management in NICUs is extremely manual, labor-intensive anderror prone. Keriton is working with Penn Medicine to develop a new gold-standard for breast milk management. With end-to-end process automation and validation, Keriton's HIPAA-compliant SaaS suite significantly lowers the nurses’ time spent on breast milk management, reduces errors and automatically generates an audit trail for the process. The Keriton suite also aims to improve expression of breast milk in lactating NICU mothers by enhancing their pumping experience, which has been empirically linked to improved clinical outcomes. Keriton delivers on all 3 aspects of AHA's triple goals i.e. improved outcomes, reduced cost and better patient engagement with a possible ROI of $4.5M per average sized NICU.
MedAware — Our AI-powered medication safety monitoring platform identifies preventable medication-related risks at all stages of the patient journey.
MPOWER Financing — Apply for international student loans through MPOWER Financing. Our student loans to study in the USA & Canada don't require a cosigner or credit history.

Bradley M. Bloom is the Managing Director at Berkshire Partners.

Investment focus

Artificial Intelligence, Food and Beverage, Sports
Funding Round, Seed, Series A
Israel, United States

Portfolio highlights

Perch — Perch brings velocity based training into the 21st century. No strings. No wearables. Learn more about how Perch enables VBT and weight room technology!
Diagnostic Robotics — Diagnostic Robotic develops a signal-agnostic artificial intelligence system for healthcare insurers, providers, and patients. It allows to build powerful predictive analytics models that will solve a world-wide challenge, strained health budgets, and workforces. Diagnostic Robotic was founded on 2017 and is headquartered in Tel Aviv, Israel.
AUI™ (Augmented Intelligence) Inc. — Apollo is a groundbreaking language model that combines the best of generative and rule-based AI to create agents that can be tailored to any business.

Tzachi Arabov is a owner of ACRO.

Investment focus

Medical Device, Clinical Trials, Health Diagnostics
Seed
Israel

Portfolio highlights

MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable

Josh Riff is the co-founder of Included Health.

Investment focus

Software, Wellness, Analytics
Seed
Israel

Portfolio highlights

Laguna Health — Laguna is a tech company solving a huge, costly problem in US healthcare. We provide easier post-hospitalization recovery soultions.

Itsik Danziger - Chairman of the Board @ The Center for Educational Technology (CET)

Investment focus

Medical, Hospital, Health Care
Series A
Israel

Portfolio highlights

EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.

For the last 10 years, I have been active within the Israeli and US startup ecosystems where I completed 20+ seed investments in companies such as Geoforce (acquired by LLR), Bonobo (acquired by Salesforce), Optitex (acquired by Efi), Keeprz (acquired by Como), Drippler (acquired by Soluto), Snyk (Unicorn) and few others. I am passionate for seedinvestments, creative ideas, risk taking and supporting entrepreneurs.Prior to that, I founded 2 companies, Blue Sky (Energy) and Sinusafe (Medical) after working as a software engineer for 7 years.I grew up in Israel, and lived in the US for 5 years while completing my MBA from Duke. I love all kinds of extreme sports, and particularly kite surfing and snowboarding.

Investment focus

Software, Artificial Intelligence, Machine Learning
Seed, Funding Round, Series B
Israel, United States

Portfolio highlights

Laxis — Learn how UX designers, product managers, market research, consultants, and attorneys use conversation Intelligence to supercharge their business and increase revenue. Learn more.
Deci AI — Deci enables deep learning to live up to its true potential by using AI to build better AI. With the company’s end-to-end deep learning acceleration platform, AI developers can build, optimize, and deploy faster and more accurate models for any environment, including cloud, edge or mobile. With Deci’s platform, developers can increase deeplearning model inference performance by 3x-15x, on any hardware, while still preserving accuracy. This translates directly into new use cases on limited hardware, substantially shorter development cycles, and reduced compute costs by up to 80%. The platform is powered by Deci’s Automated Neural Architecture Construction (AutoNAC) technology, an algorithmic optimization engine that squeezes maximum utilization out of any hardware. The AutoNAC engine contains a Neural Architecture Search (NAS) component that redesigns a given trained model’s architecture to optimally improve its inference performance (throughput, latency, memory, etc.) for specific target hardware while preserving its baseline accuracy. Deci achieved a record-breaking 11.8x accelerated inference speedup on Intel CPUs at MLPerf Industry Benchmark and has been named to the CBInsights top 100 AI companies. Led by a team of world-class deep learning experts, Deci lets AI developers focus on what they do best - creating innovative AI-based solutions for our world’s most complex problems.
Velocity — Accelerate the way you build and deliver products. Spin up fully isolated, production-like environments in seconds. Work with your existing dev toolbox.

David E. Weekly is the Head of The Capital One Lab of Capital One. He previously worked at Medcorder as a Founder and CEO. David E. Weekly attended Stanford University.

Investment focus

Robotics, Drones, Aerospace
Seed, Angel, Pre-Seed
United States, Israel

Portfolio highlights

Mast Reforestation — No-cost reforestation for post-wildfire burned acreage for landowners and foresters, funded by carbon removal credits.
Sugarlogix — A precise reflection of human milk to provide the best nutrition for babies
Mast Reforestation — No-cost reforestation for post-wildfire burned acreage for landowners and foresters, funded by carbon removal credits.

Moshe Shoham

Investment focus

Medical, Health Care, Artificial Intelligence
Pre-Seed
Israel

Portfolio highlights

Predicta Med — Predicta Med is a decision support platform for early detection and intervention selection of autoimmune diseases. Our platform gives healthcare providers an AI-powered method for shortening the diagnostic process of identifying autoimmune diseases and by that could enhance provider’s efficiency, improve treatment effectiveness and patient'scare. A process which typically takes more than four years and at least four different doctors can be shortened significantly using our platform.

Rafi Gidron is the Chairman and Co-Founder of Xperiti. He attended Columbia University.

Investment focus

Artificial Intelligence, Cyber Security, Financial Services
Seed, Angel, Series B
Israel, United States, United Kingdom

Portfolio highlights

Blyp — Blyp is an AI-driven data analytics platform for e-commerce companies.
Vyzer — One platform for investment tracking, financial planning, data-driven insights, document analysis & more! Ideal for diverse portfolios.
GlossAI — Detect, analyze, and monitor every brand-related video with GlossAi's Social Watching platform. Enhance your brand protection, get video insights, real-time marketing, and influencer selection. Monitor and analyze videos to elevate your brand's online presence today!

Nir Kalkstein is an entrepreneur, a data scientist and a recognized expert in Big Data and machine learning algorithms. Nir co-founded Final, one of the most successful algo-trading companies worldwide. In 2009 He co-founded Medial with the vision of creating data-driven best-in-class predicative tools that provide physicians with actionableinsights to save lives. Nir has devoted significant intellectual and financial resources to support the ongoing success of the research for the Company, initially as the sole financier, and is committed to reinvesting his future profits into further research. Nir holds a BSc in Electrical Engineering from the Israeli Technion Institute of Technology.

Investment focus

Machine Learning, Health Care, Artificial Intelligence
Seed, Series B
Israel

Portfolio highlights

Nucleai — Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.
Medial EarlySign — Medial EarlySign develops an AI algorithmic platform for the discovery of clinical insights that indicate the likelihood of disease from basic medical information, such as blood test results, and other EMR data. Called AlgoMarkers, its predictive engines are built in collaboration with healthcare organizations, through the combination of 10s ofmillions of patient years-worth of data, clinical rigor and some of the most brilliant algorithmic minds. The company develops clinical decision support and population health solutions that can assist in the early prediction of clinical outcomes related to cancers, metabolic, immune and infectious diseases. These tools are designed to place at the fingertips of healthcare organizations only those insights that could prove critical in disease management and prevention empowering them with proactive, predictive and personalized care management capabilities

Alan Patricof is the founder and Chairman Emeritus and was a managing director of Greycroft. He is a Co-founder and Chairperson at Primetime Partners and was a Founder at Apax Partners. Alan attended Columbia Business School and The Ohio State University.

Investment focus

Financial Services, Finance, Health Care
Series A, Seed, Funding Round
United States, Kenya, Spain

Portfolio highlights

Leena AI — Leena AI is a Gen AI employee assistant that reduces IT, HR, Finance tickets. We guarantee 70% self-service ratio in the contract.
Racket — Let's make a racket.
Alpha Tau Medical — Alpha Tau Medical provides highly potent and conformal Alpha Radiotherapy (Alpha DaRT) for solid cancer tumors.

Investors by industry

Artificial intelligence